Efficacy of Saxagliptin versus Mitiglinid in patients with type 2 diabetes and end-stage renal disease

Efficacy of Saxagliptin versus Mitiglinid in patients with type 2 diabetes and end-stage renal disease

Abstract Background There are very few oral antidiabetic drugs recommended for patients on dialysis. Saxagliptin is known for its potent effect and long duration of action. In this study, we compared the efficacy of Saxagliptin with Mitiglinid for diabetes control and renal anemia in hemodialysis pa...

Full description

Bibliographic Details
Main Authors: Yukinao Sakai, Saori Sakai, Koji Mugishima, Anna Katayama, Yuichiro Sumi, Yusuke Otsuka, Tomoyuki Otsuka, Shuichi Tsuruoka
Format: Article
Language:English
Published: BMC 2017-04-01
Series:Renal Replacement Therapy
Subjects:
End-stage renal disease
Diabetes mellitus
Hemodialysis
DPP-4 inhibitor
Saxagliptin
Glycated albumin
Online Access:http://link.springer.com/article/10.1186/s41100-017-0098-7

Internet

http://link.springer.com/article/10.1186/s41100-017-0098-7

Similar Items